is semaglutide banned by wada just added tirzepatide (mounjaro) to the 2026 Monitoring Program GLP-1 drugs (like semaglutide) aid

Patients might be asked to keep a diary of their daily activities, food intake, and any new products they have used on their skin to help pinpoint potential triggers

It may prompt closer attention to how Novo Nordisk balances price, volume and portfolio mix, and how peers respond as similar patent cliffs approach globally

Cardiovascular Outcomes Liraglutide (LEADER trial): 13% reduction in major adverse cardiovascular events (MACE) in patients with Type 2 diabetes and high cardiovascular risk Statistically significant cardiovascular protection Semaglutide (SELECT trial): 20% reduction in MACE in patients with obesity and established cardiovascular disease Studied specifically for cardiovascular outcomes in obesity (not just diabetes) Both medications provide cardiovascular protection, but semaglutides evidence is more recent, more robust, and specifically applicable to patients with obesity regardless of diabetes status

Semaglutide may be used by those with hypothyroidism, but only under careful healthcare provider supervision to avoid interactions and manage symptoms effectively

Early comparisons with dual GIP/GLP-1 agonists suggested that Retatrutides triple agonist approach was well-tolerated and potentially more effective

These include sitagliptin, saxagliptin, linagliptin, and alogliptin